- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Important, 16-07-2026: Updates
16-07-2026 | 08:43 am
16-07-2026 | 08:43 am
Biocon Malaysia received EMA approval for its new insulin fill-finish unit. This expands manufacturing capacity for Semglee® (insulin glargine), enabling European market supplies to commence in Q2FY27.
No comments yet. Be the first to comment!